10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Unveiling the Multifaceted Mechanisms of Antibacterial Activity of Buforin II and Frenatin 2.3S Peptides from Skin Micro-Organs of the Orinoco Lime Treefrog ( Sphaenorhynchus lacteus)

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Amphibian skin is a rich source of natural compounds with diverse antimicrobial and immune defense properties. Our previous studies showed that the frog skin secretions obtained by skin micro-organs from various species of Colombian anurans have antimicrobial activities against bacteria and viruses. We purified for the first time two antimicrobial peptides from the skin micro-organs of the Orinoco lime treefrog ( Sphaenorhynchus lacteus) that correspond to Buforin II (BF2) and Frenatin 2.3S (F2.3S). Here, we have synthesized the two peptides and tested them against Gram-negative and Gram-positive bacteria, observing an effective bactericidal activity at micromolar concentrations. Evaluation of BF2 and F2.3S membrane destabilization activity on bacterial cell cultures and synthetic lipid bilayers reveals a distinct membrane interaction mechanism. BF2 agglutinates E. coli cells and synthetic vesicles, whereas F2.3S shows a high depolarization and membrane destabilization activities. Interestingly, we found that F2.3S is able to internalize within bacterial cells and can bind nucleic acids, as previously reported for BF2. Moreover, bacterial exposure to both peptides alters the expression profile of genes related to stress and resistance response. Overall, these results show the multifaceted mechanism of action of both antimicrobial peptides that can provide alternative tools in the fight against bacterial resistance.

          Related collections

          Most cited references62

          • Record: found
          • Abstract: not found
          • Book Chapter: not found

          Protein Identification and Analysis Tools on the ExPASy Server

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found
            Is Open Access

            Mechanisms and consequences of bacterial resistance to antimicrobial peptides.

            Cationic antimicrobial peptides (AMPs) are an intrinsic part of the human innate immune system. Over 100 different human AMPs are known to exhibit broad-spectrum antibacterial activity. Because of the increased frequency of resistance to conventional antibiotics there is an interest in developing AMPs as an alternative antibacterial therapy. Several cationic peptides that are derivatives of AMPs from the human innate immune system are currently in clinical development. There are also ongoing clinical studies aimed at modulating the expression of AMPs to boost the human innate immune response. In this review we discuss the potential problems associated with these therapeutic approaches. There is considerable experimental data describing mechanisms by which bacteria can develop resistance to AMPs. As for any type of drug resistance, the rate by which AMP resistance would emerge and spread in a population of bacteria in a natural setting will be determined by a complex interplay of several different factors, including the mutation supply rate, the fitness of the resistant mutant at different AMP concentrations, and the strength of the selective pressure. Several studies have already shown that AMP-resistant bacterial mutants display broad cross-resistance to a variety of AMPs with different structures and modes of action. Therefore, routine clinical administration of AMPs to treat bacterial infections may select for resistant bacterial pathogens capable of better evading the innate immune system. The ramifications of therapeutic levels of exposure on the development of AMP resistance and bacterial pathogenesis are not yet understood. This is something that needs to be carefully studied and monitored if AMPs are used in clinical settings.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions.

              The mechanism of action of buforin II, which is a 21-amino acid peptide with a potent antimicrobial activity against a broad range of microorganisms, was studied using fluorescein isothiocyanate (FITC)-labeled buforin II and a gel-retardation experiment. Its mechanism of action was compared with that of the well-characterized magainin 2, which has a pore-forming activity on the cell membrane. Buforin II killed Esche-richia coli without lysing the cell membrane even at 5 times minimal inhibitory concentration (MIC) at which buforin II reduced the viable cell numbers by 6 orders of magnitude. However, magainin 2 lysed the cell to death under the same condition. FITC-labeled buforin II was found to penetrate the cell membrane and accumulate inside E. coli even below its MIC, whereas FITC-labeled magainin 2 remained outside or on the cell wall even at its MIC. The gel-retardation experiment showed that buforin II bound to DNA and RNA of the cells over 20 times strongly than magainin 2. All these results indicate that buforin II inhibits the cellular functions by binding to DNA and RNA of cells after penetrating the cell membranes, resulting in the rapid cell death, which is quite different from that of magainin 2 even though they are structurally similar: a linear amphipathic alpha-helical peptide.
                Bookmark

                Author and article information

                Journal
                Int J Mol Sci
                Int J Mol Sci
                ijms
                International Journal of Molecular Sciences
                MDPI
                1422-0067
                25 July 2018
                August 2018
                : 19
                : 8
                : 2170
                Affiliations
                [1 ]Department of Biomedical Engineering, Universidad de los Andes, Bogotá 111711, Colombia; c.munoz2016@ 123456uniandes.edu.co
                [2 ]Laboratorio de Genética Humana, Department of Biological Sciences, Universidad de los Andes, Bogotá 111711, Colombia; visalazar@ 123456uniandes.edu.co (V.A.S.); la.barrero1854@ 123456uniandes.edu.co (L.B.-G.); sandracamargouis@ 123456gmail.com (S.C.)
                [3 ]Department of Biochemistry and Molecular Biology, Faculty of Biosciences, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Spain; angela.mosquera@ 123456udea.edu.co
                [4 ]Institute of Life Sciences, Hebrew University of Jerusalem, Jerusalem 91904, Israel
                [5 ]Biotechnology Group, Biology Institute, Universidad de Antioquia, Medellín 050010, Colombia
                Author notes
                [* ]Correspondence: hgroot@ 123456uniandes.edu.co (H.G.); ester.boix@ 123456uab.cat or Ester.Boix@ 123456uab.es (E.B.); Tel.: +57-1-339-49-49 (ext. 2771) (H.G.); +34-935-81-25-65 (E.B.)
                Author information
                https://orcid.org/0000-0003-0164-4732
                https://orcid.org/0000-0003-1790-2142
                Article
                ijms-19-02170
                10.3390/ijms19082170
                6121439
                30044391
                d02afb6d-d064-4245-8e44-4ca54312facb
                © 2018 by the authors.

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( http://creativecommons.org/licenses/by/4.0/).

                History
                : 09 July 2018
                : 19 July 2018
                Categories
                Article

                Molecular biology
                antibacterial activity,antimicrobial peptides,bacterial agglutination,buforin ii,dna binding,frenatin 2.3s,frog skin secretions,membrane translocation,membrane leakage

                Comments

                Comment on this article